|Day Low/High||3,140.67 / 3,240.81|
|52 Wk Low/High||1,626.03 / 3,344.29|
Let me disabuse you of some of the biggest canards that people routinely spout involving the Fed and stocks.
Anyone playing the guessing game into earnings is rolling the dice.
* Optimism is the enemy of the rational buyer * Instead of a vaccine needed to help the economy, investors seem to think Fed policy is the innoculation from stock market losses * Speculators, Robinhood and David Portnoy are bit players and a market ...
The Fed will release its policy statement at 2 pm Eastern time Wednesday.
These House antitrust hearings are ridiculous given that the companies on the hot seats are about the best thing we have going for us.
In a 'normal' recession, these would be real losers -- but right now? They look like numero 'UNO'.
And there is a particular Brazilian ETF that is worth exploring if you want to take advantage of rising commodity prices and the falling U.S. dollar.
On Monday morning, Paul Sweeney and Tom Keene and I discussed Amazon , convexity (bonds), equities, Major League Baseball (go NY YANKEES), trading vs. long term investing, shorting, Robinhood's Merry Men (and their influence on the markets), TINA ("...
Four reasons why August will be the month the pandemic really hits for Americans.
Firms should be using their high stock price to grab other businesses to expand, so they're ready when things return to normal.
Monetary policy, fiscal policy, and major earnings news are all on the docket.
What has changed significantly has been the value of the U.S. dollar relative to peer currencies.
Why aren't we figuring out how to cure the test bottleneck?
I'm doing some dip buying amid weakness in large-cap tech stocks.
CRBP has topline Phase 3 data for its primary compound Lenabasum for Systemic Sclerosis due out this summer.
* Will the Embassy tit for tat be the nail in the market (that many haven't been looking at) and be the catalyst for the market's relentless advance from March to end? * Yesterday's outside day may have been a dark moment in time for the markets and...
FATMAANN names are leading to the downside, but small-caps and value are outperforming.
Plus, why shares of vaccine maker Moderna are taking a hit.
Investors might have to take it on the chin -- and then do some soul searching -- as names like Microsoft, Tesla and other stars get hit.
Let's see where the greenback goes from here, because that will be revealing in multiple ways.
The bears have predicted a negative reaction to earnings for many years and have seldom been rewarded for their pessimism. Microsoft will be a good test case Thursday.
It will not collapse on valuation, fraud, currently non-existent inflation or its own weight. But here's what could knock it off its feet.
Walgreens Boots Alliance lets you collect 4.6% dividend yield, while you wait for the turnaround.
Various hard-charging mega-cap stocks seem overdue for a significant pause, while a drop in Acadia Pharmaceuticals sets up an options play.
The markets are really in the hands of Washington right now, and Washington is in the hands of the virus.
Yesterday afternoon I opined (in "Is Today a Short-Term Peak In 'At Home' Plays?") that the abrupt and sizable move higher in Amazon , Netflix , Zoom , Shopify , and other at home equities was reminiscent of the short-term peak in bank stocks on Jun...
Even the president has switched sides on this issue that could help flatten the curve and help get the economy rolling again.
Here's how to play the stock now.
The magnitude of the large daily per share and market cap dollar gains in Tesla , Amazon , etc. is now comparable, and in certain cases more extreme, than what occurred in the dot.com era. What is forgotten is that large cap technology joined the s...